Early onset familial Alzheimer’s disease is a rare genetic form of Alzheimer’s that strikes people well before the typical age of 65, sometimes as early as their 30s or 40s. Understanding this condition helps families recognize symptoms early and access the support they need during an unexpected and challenging journey.
Epidemiology
Early onset familial Alzheimer’s disease, also called EOFAD, represents a small fraction of all Alzheimer’s cases. Less than 5% of Alzheimer’s disease overall is caused by a single genetic mutation that runs in families.[1] When looking specifically at people who develop Alzheimer’s before age 65—referred to as early-onset Alzheimer’s—only about 5 to 10% of these cases are linked to inherited genetic mutations.[2]
About 110 of every 100,000 adults between ages 30 and 64 have young-onset Alzheimer’s.[5] This means that while Alzheimer’s affecting younger people is uncommon, within that group only a fraction have the familial form caused by specific genetic mutations. In fact, only a few hundred people worldwide are known to carry the genes that cause EOFAD.[12]
The disease does not discriminate by gender. It affects men and women equally.[12] When someone has a mutation in one of the EOFAD genes, each of their children faces a 50% chance of inheriting that same mutation.[1] This creates a pattern where multiple family members across generations may develop symptoms at similar ages.
In families affected by EOFAD, people usually show symptoms well before age 65. Symptoms can begin as early as the 30s or 40s, though most people with early-onset Alzheimer’s first notice changes between ages 45 and 64.[1][8] This is strikingly different from typical Alzheimer’s, which overwhelmingly affects people 65 and older.
Causes
The root cause of early onset familial Alzheimer’s disease lies in changes to specific genes. To date, scientists have identified 230 mutations in three particular genes that cause EOFAD.[3] These three genes are Presenilin 1 (PS1 or PSEN1) on chromosome 14, Presenilin 2 (PS2 or PSEN2) on chromosome 1, and Amyloid precursor protein (APP) on chromosome 21.[1][2]
When a mutation occurs in any of these three genes, it disrupts a common pathway in the brain. Specifically, the mutations affect how the body produces and breaks down a protein fragment called amyloid beta peptide. These mutations lead to excessive production of this toxic protein fragment in the brain.[3][6]
Amyloid beta peptide has a harmful tendency to clump together. When too much is produced, it builds up in the brain and forms sticky deposits called amyloid plaques. These plaques are one of the hallmark features of Alzheimer’s disease.[6] The accumulation of these toxic clumps appears to damage nerve cells in the brain, eventually leading to their death.
Among the three genes, mutations in PSEN1 are the most common cause of familial Alzheimer’s disease.[12] The inheritance pattern for EOFAD is called autosomal dominant. This term means that if a parent carries one of these mutations, each child has a 50% (1 in 2) chance of inheriting it.[1] If a child does inherit the mutation, they will likely develop Alzheimer’s disease before age 65.[5]
Unlike some genetic conditions that require mutations from both parents, EOFAD only requires inheriting one copy of a mutated gene to cause the disease.[12] The disease does not skip generations—it follows a clear family pattern where affected individuals often have parents, aunts, uncles, or grandparents who also developed early-onset Alzheimer’s.[12]
Risk Factors
The primary risk factor for early onset familial Alzheimer’s disease is having a family history of the condition. If you have a parent or grandparent with young-onset Alzheimer’s caused by a genetic mutation, your risk of developing the disease increases significantly.[5] However, having a family history does not guarantee that you will develop the disease—it depends on whether you inherited the specific mutation.
About 60% of all early-onset Alzheimer’s cases have a positive family history, meaning the person has relatives who also had Alzheimer’s. Of those, 13% are inherited in an autosomal dominant manner—meaning they are caused by one of the three known EOFAD genes.[2] This leaves a large portion of early-onset cases where the cause is not clearly genetic or where researchers have not yet identified the specific genes involved.
People who have a known mutation in PSEN1, PSEN2, or APP genes are at extremely high risk—nearly certain—to develop early-onset Alzheimer’s if they live long enough.[12] For these individuals, the question is not if they will develop symptoms, but when.
There is also a connection between early-onset Alzheimer’s and Down syndrome. People with Down syndrome are born with an extra copy of chromosome 21, which contains the APP gene. This means they have three copies of the APP gene instead of the usual two. The extra production of amyloid beta peptide may explain why people with Down syndrome have an increased risk of developing Alzheimer’s disease.[6] However, this type of Alzheimer’s is not inherited and accounts for less than 1% of all Alzheimer’s cases.
For most people with early-onset Alzheimer’s, the cause is not related to any single gene, and researchers do not fully understand why some people develop the disease at a younger age than others.[5] Some potential risk factors that have been studied include head injuries, cardiovascular health conditions like high blood pressure and diabetes, and lower levels of education or mental stimulation, though these are more commonly associated with late-onset Alzheimer’s rather than the familial form.[17]
Symptoms
The symptoms of early onset familial Alzheimer’s disease mirror those of typical Alzheimer’s, but they appear at a much younger age. The disease causes a progressive decline in mental abilities, meaning symptoms gradually worsen over time as the disease damages more of the brain.[8]
Memory loss is the most common and recognizable symptom. At first, people may have trouble remembering recent events or the names of people and things. This is different from occasionally misplacing your keys—it is a persistent and worsening inability to remember important information.[2][8] As the disease progresses, memory problems become more severe and can affect long-term memories as well.
Language difficulties, called aphasia, are common. People may struggle to find the right word when speaking or writing. They might communicate less than they used to or use the wrong words when trying to express themselves.[2][8] Following conversations may also become challenging.
Early-onset Alzheimer’s affects a person’s ability to think clearly and solve problems. Tasks that used to be easy, like following a recipe or managing finances, can become confusing and difficult. People may take an unusually long time to make decisions or seem confused about what to do next, even when they have instructions.[2][8]
Confusion about time and place is another symptom. People with EOFAD may forget where they are or how they got there, even in familiar settings like their own home.[2] This spatial disorientation can be frightening for both the person experiencing it and their loved ones.
Changes in behavior and personality can be particularly distressing for families. A person with early-onset Alzheimer’s might become more suspicious of others, even people they have known for years. They may experience mood swings, feel more aggressive or impulsive than usual, or show increased agitation.[2][8] Some people withdraw from work or social activities they once enjoyed.
Physical symptoms can also appear. Vision problems, balance issues, and trouble with coordination are possible. People may bump into furniture more often or have difficulty with delicate hand movements like tying shoes or typing.[2][8] Other symptoms reported include hallucinations, seizures, decreased muscle tone, and movement problems similar to Parkinson’s disease.[2]
In the later stages of the disease, symptoms become more severe. People may lose the ability to communicate entirely, stop recognizing loved ones, and require help with all basic activities like eating, bathing, and dressing.[2] Eventually, individuals with Alzheimer’s disease require total care.
It is important to note that recognizing symptoms in oneself can be difficult, especially in the early stages. Loved ones are often the first to notice subtle changes that the person experiencing them cannot see.[8] If you or someone you trust notices any of these symptoms, it is important to see a healthcare provider as soon as possible.
Prevention
Because early onset familial Alzheimer’s disease is caused by specific genetic mutations, there is currently no way to prevent the disease in people who carry these mutations. If a person inherits one of the three EOFAD gene mutations from a parent, they will almost certainly develop the disease if they live long enough.[5]
For families affected by EOFAD, genetic counseling is an important resource. Individuals with a family history of early-onset Alzheimer’s should consider genetic counseling to assess their risk and discuss whether genetic testing is right for them.[17] Genetic testing can detect mutations in the PS1, PS2, and APP genes.[1] Knowing whether you carry a mutation allows you to make informed decisions about your future, including family planning, career choices, and legal and financial planning.
However, deciding whether to undergo genetic testing is deeply personal. Some people want to know their genetic status so they can plan ahead, while others prefer not to know. Genetic counseling helps individuals understand the implications of testing, including the emotional, social, and practical consequences of knowing—or not knowing—their genetic risk.
While there is no prevention for those with EOFAD mutations, researchers are working to better understand how lifestyle and environmental factors might influence when symptoms begin or how quickly the disease progresses. Some studies suggest that maintaining cardiovascular health, staying mentally and socially engaged, and avoiding head injuries may play a role in brain health, though these factors are less clear in familial Alzheimer’s compared to sporadic cases.[17]
Pathophysiology
The pathophysiology of early onset familial Alzheimer’s disease involves complex changes in how the brain functions at the cellular level. At its core, the disease is caused by the abnormal accumulation of proteins in the brain, specifically amyloid beta peptide and a protein called tau.[8]
The brain contains billions of nerve cells called neurons, which allow us to think, learn, remember, and plan. Neurons communicate with each other by sending electrical and chemical signals back and forth. When the genes for PS1, PS2, or APP are mutated, large amounts of amyloid beta peptide are produced.[3][6] This toxic protein fragment clumps together to form sticky deposits called amyloid plaques between neurons in the brain.
At the same time, tau proteins inside neurons twist together to form fiber-like tangles. Both the plaques outside cells and the tangles inside cells prevent neurons from working properly. They block the neurons’ ability to send signals to each other.[8] Over time, this buildup of plaques and tangles causes neurons to die.
The death of neurons starts in one area of the brain and then spreads to other areas. As more and more brain cells are destroyed, the brain begins to shrink, a process called atrophy. This progressive damage leads to the worsening symptoms of Alzheimer’s disease—from memory loss and confusion to the eventual loss of all cognitive and physical functions.[8]
In EOFAD, the mutations in PS1, PS2, and APP genes all affect the same pathway: how the body produces and processes amyloid beta peptide. The mutations cause the body to produce too much of this toxic fragment, or to produce forms of it that are more likely to clump together. This excessive production and accumulation of amyloid beta is believed to set off a chain reaction that eventually leads to widespread brain damage and the symptoms of Alzheimer’s disease.[3][6]
